John Medich - Articles and news items

AbbVie Logo

AbbVie presents phase II data evaluating the efficacy of Humira® in patients with Hidradenitis Suppurativa (HS), a chronic inflammatory skin disease

Industry news / 3 October 2013 / AbbVie

The post-hoc analysis applies a new measurement tool created by AbbVie to assess the efficacy of HS therapy…

Abbott logo

Abbott announces data evaluating reduction of steroid usage with HUMIRA® (Adalimumab)

Industry news, News / 24 October 2012 / Abbott

“These data suggest that adalimumab-treated patients were able to reduce steroid usage…”

Abbott logo

Abbott announces new data evaluating mucosal healing with HUMIRA® (Adalimumab)

Industry news, News / 23 October 2012 / Abbott

Results from a post-hoc sub-analysis…

Abbott logo

Abbott presents Phase 3 study results for investigational use of HUMIRA®

Industry news, News / 6 June 2012 / Abbott

First Phase 3 study to evaluate an anti-TNF in patients with non-radiographic axial spondyloarthritis…

Abbott logo

Abbott announces 10-Year data evaluating HUMIRA® (Adalimumab)

Industry news, News / 6 June 2012 / Abbott

Abbott announced results from two long-term, open-label studies…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...